These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 11106327)
1. A modified, optimized kinetic photometric assay for the determination of blood coagulation factor XIII activity in plasma. Kárpáti L; Penke B; Katona E; Balogh I; Vámosi G; Muszbek L Clin Chem; 2000 Dec; 46(12):1946-55. PubMed ID: 11106327 [TBL] [Abstract][Full Text] [Related]
2. Kinetic determination of blood coagulation Factor XIII in plasma. Muszbek L; Polgár J; Fésüs L Clin Chem; 1985 Jan; 31(1):35-40. PubMed ID: 2856900 [TBL] [Abstract][Full Text] [Related]
3. A photometric assay for blood coagulation factor XIII. Fickenscher K; Aab A; Stüber W Thromb Haemost; 1991 May; 65(5):535-40. PubMed ID: 1871715 [TBL] [Abstract][Full Text] [Related]
4. Measurement of factor XIII activity in plasma. Katona É; Pénzes K; Molnár É; Muszbek L Clin Chem Lab Med; 2012 Feb; 50(7):1191-202. PubMed ID: 22850052 [TBL] [Abstract][Full Text] [Related]
5. Assessment of Factor XIII. Muszbek L; Katona É; Kerényi A Methods Mol Biol; 2017; 1646():277-293. PubMed ID: 28804836 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of a sensitive colorimetric FXIII incorporation assay. Effects of FXIII Val34Leu, plasma fibrinogen concentration and congenital FXIII deficiency. Wilmer M; Rudin K; Kolde H; Poetzsch B; Lenz W; Moessmer G; Meili E; Egbring R; Gempeler-Messina P; Gempeler M; Bastian S; Kohler H Thromb Res; 2001 Apr; 102(1):81-91. PubMed ID: 11323018 [TBL] [Abstract][Full Text] [Related]
7. Measurement of factor XIII (FXIII) activity by an automatic ammonia release assay using iodoacetamide blank-procedure: no more overestimation in the low activity range and better detection of severe FXIII deficiencies. Cini M; Legnani C; Frascaro M; Pancani C; Cappelli C; Rodorigo G; Valdrè L; Cosmi B Clin Chem Lab Med; 2016 May; 54(5):805-9. PubMed ID: 26457781 [TBL] [Abstract][Full Text] [Related]
8. A highly sensitive fluorometric assay for determination of human coagulation factor XIII in plasma. Oertel K; Hunfeld A; Specker E; Reiff C; Seitz R; Pasternack R; Dodt J Anal Biochem; 2007 Aug; 367(2):152-8. PubMed ID: 17582378 [TBL] [Abstract][Full Text] [Related]
9. A photometric method for the dosage of factor XIII applied to the study of chronic hepatopathies. Ballerini G; Gemmati D; Moratelli S; Morelli P; Serino ML Thromb Res; 1995 Jun; 78(5):451-6. PubMed ID: 7660361 [TBL] [Abstract][Full Text] [Related]
10. Factor XIII Deficiency. Karimi M; Bereczky Z; Cohan N; Muszbek L Semin Thromb Hemost; 2009 Jun; 35(4):426-38. PubMed ID: 19598071 [TBL] [Abstract][Full Text] [Related]
11. Rapid determination of blood coagulation factor XIII activity using protein arrays for serodiagnosis of human plasma. Kwon MH; Kong DH; Jung SH; Suh IB; Kim YM; Ha KS Anal Chem; 2011 Mar; 83(6):2317-23. PubMed ID: 21323342 [TBL] [Abstract][Full Text] [Related]
12. [Condition setting for the measurement of blood coagulation factor XIII activity using a fully automated blood coagulation analyzer, COAGTRON-350]. Kanno N; Kaneko M; Tanabe K; Jyona M; Yokota H; Yatomi Y Rinsho Byori; 2012 Dec; 60(12):1131-8. PubMed ID: 23427694 [TBL] [Abstract][Full Text] [Related]
13. Factor XIII deficiency enhances thrombin generation due to impaired fibrin polymerization - An effect corrected by Factor XIII replacement. Pitkänen HH; Jouppila A; Lemponen M; Ilmakunnas M; Ahonen J; Lassila R Thromb Res; 2017 Jan; 149():56-61. PubMed ID: 27902939 [TBL] [Abstract][Full Text] [Related]
14. Automation of a Factor XIII Activity Assay Utilizing a Plasma Blank Measurement. Smock KJ; Moser KA Methods Mol Biol; 2023; 2663():693-706. PubMed ID: 37204746 [TBL] [Abstract][Full Text] [Related]
15. Clinical Validation of an Automated Fluorogenic Factor XIII Activity Assay Based on Isopeptidase Activity. Leitner M; Büchold C; Pasternack R; Binder NB; Moore GW Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498248 [TBL] [Abstract][Full Text] [Related]
16. Screening cleavage of Factor XIII V34X Activation Peptides by thrombin mutants: A strategy for controlling fibrin architecture. Jadhav MA; Goldsberry WN; Zink SE; Lamb KN; Simmons KE; Riposo CM; Anokhin BA; Maurer MC Biochim Biophys Acta Proteins Proteom; 2017 Oct; 1865(10):1246-1254. PubMed ID: 28687225 [TBL] [Abstract][Full Text] [Related]
17. Development and evaluation of a modified colorimetric solid-phase microassay for measuring the activity of cellular and plasma (Factor XIII) transglutaminases. Thomas V; El Alaoui S; Massignon D; Clément S; Simonet F; Quash G Biotechnol Appl Biochem; 2006 Mar; 43(Pt 3):171-9. PubMed ID: 16313237 [TBL] [Abstract][Full Text] [Related]
18. Quantification of coagulation factor XIII activity by a thio-NADH based assay using factor XIII immuno-depleted plasma as a diluent for calibration. Kappel A; Stephan S; Christ G; Pechmann L; Duwe C; Fischer B; Hahn M; Althaus H; Ehm M; Schwarz H; Vitzthum F Clin Chem Lab Med; 2010 Dec; 48(12):1739-43. PubMed ID: 20828366 [TBL] [Abstract][Full Text] [Related]
19. A highly sensitive chemiluminescence immunoassay for the measurement of coagulation factor XIII subunits and their complex in tears. Orosz ZZ; Katona E; Facskó A; Berta A; Muszbek L J Immunol Methods; 2010 Feb; 353(1-2):87-92. PubMed ID: 20079358 [TBL] [Abstract][Full Text] [Related]
20. Monocytes of patients congenitally deficient in plasma factor XIII lack factor XIII subunit a antigen and transglutaminase activity. Muszbek L; Adány R; Kávai M; Boda Z; Lopaciuk S Thromb Haemost; 1988 Apr; 59(2):231-5. PubMed ID: 2898817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]